Shield Therapeutics plc (SHIEF OTCQB) stock market data APIs
$0.0851
0(0%)
as of September 8, 2026
Try our APIs with
free plan!
Shield Therapeutics plc Financial Data Overview
Price chart is built with
Anychart
Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru (ferric maltol), a non-salt based oral therapy for patients to treat the iron deficiency with or without anemia. Shield Therapeutics plc was incorporated in 2008 and is based in Gateshead, United Kingdom.
Prev. Close
0.0851
Open
0.0851
High
0.0851
Low
0.0851
52 wk Range
0.0521-0.1679
Market Cap
91 584 K
Shares Outstanding
1 070 M
Revenue
58 625 K
EPS
-0.0275
Beta
1.768
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Shield Therapeutics plc data using free add-ons & libraries
Get Shield Therapeutics plc Fundamental Data
Shield Therapeutics plc Fundamental data includes:
- Net Revenue: 58 625 K
- EBITDA: -4 429 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Shield Therapeutics plc News
New
Cavendish reiterates 'buy' rating on Shield Therapeutics after US deal with Viatris
Cavendish has reiterated its buy rating on Shield Therapeutics PLC (AIM:STX, OTCQB:SHIEF) following the pharmaceutical company's agreement to take full commercial control of its main United States (U...
Shield Therapeutics jumps 11% as losses narrow and profitability target held
Shield Therapeutics jumps 11% as losses narrow and profitability target held Proactive uses images sourced from Shutterstock Shares in Shield Therapeutics PLC (AIM:STX, OTCQB:SHIEF) rose 11% to 4.89p...
Shield shares jump after FDA extends Accrufer exclusivity
Shield shares jump after FDA extends Accrufer exclusivity Proactive uses images sourced from Shutterstock Broker Cavendish says additional US protection strengthens long-term outlook and reiterates b...
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentations NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) -- Life Sciences Inves...
Get Shield Therapeutics plc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
